|
||||||||||||||||
HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
BIO/MED Conference & Exhibition | ||||||||||||||||
September 03, 2003 | ||||||||||||||||
EJ Krause, Baltimore Convention Center, Baltimore Maryland December 3rd & 4th, 2003 Within the Mid-Atlantic region from NC through NJ there is more biotechnology commercial business development opportunity than almost anywhere else in the world. Our BIO/MED conference and exhibition focuses on this region’s business development for commercializing biotechnology products. BIO/MED gathers a large audience of scientists and researchers in the discovery process, entrepreneurial bio and pharma executives in the development process, clinical and medical specialists in the proving process, and informaticists, investors, venture capitalists, and service providers, with biotech visitor delegations from Asia, Canada, and Europe added to the mix. For more exhibitor or sponsorship opportunities, please visit the website at www.biomedexpo.com or call Addy Kennedy at 301-493-5500 or email kennedy@ejkrause.com |
||||||||||||||||
Organized by: | EJ Krause | |||||||||||||||
Invited Speakers: | Confirmed keynote presenters are:
§ Mark McClellan, M.D., Ph.D., Commissioner, Food and Drug Administration, Department of Health and Human Services § Steven M. Paul, M.D. Executive Vice President for Science and Technology and President of Lilly Research Laboratories, Eli Lilly and Company § William A. Haseltine, Ph.D., Chairman and Chief Executive Officer, Human Genome Sciences, Inc. § Gary Pasternack, M.D., Director, Division of Molecular Pathology, Johns Hopkins Medical Institutions § James E. Rogan, Director of the United States Patent and Trademark Office, Under Secretary of Commerce for Intellectual Property
|
|||||||||||||||
Deadline for Abstracts: | TBA | |||||||||||||||
Registration: | www.biomedexpo.com | |||||||||||||||
E-mail: | kennedy@ejkrause.com | |||||||||||||||
Posted by: | Addy Kennedy | |||||||||||||||
Host: | 5a.dbbccf.client.atlantech.net | |||||||||||||||
|
||||||||||||||||
Generated by meetings and positions 5.0 by Kai Garlipp |